Fingerprint
Dive into the research topics of 'Combretastatin (CA)-4 and its novel analogue CA-432 impair T-cell migration through the Rho/ROCK signalling pathway'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Combretastatin (CA)-4 and its novel analogue CA-432 impair T-cell migration through the Rho/ROCK signalling pathway
Jade K. Pollock*, Navin K. Verma, Niamh M. O'Boyle, Miriam Carr, Mary J. Meegan, Daniela M. Zisterer
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
15
Citations
(Scopus)